PharmaJet receives Performance, Quality and Safety pre-qualified certification from WHO

NewsGuard 100/100 Score

PharmaJet Inc. has become the first and only needle-free injection company to receive Performance, Quality and Safety (PQS) pre-qualified certification from the World Health Organization (WHO).

The WHO uses its Department of Immunization, Vaccines and Biologicals to pre-qualify vaccines and devices for safe immunizations. The Quality, Safety and Standards Team pre-qualifies a comprehensive range of cold chain equipment, injection devices and other products needed for safe and effective immunization delivery. PQS certification allows purchase and use of Stratis® jet injectors for mass immunization campaigns by WHO, The Global Alliance for Vaccines and Immunization (GAVI) and UNICEF worldwide.

Vaccine magazine's July 2012 issue reported that 24% of adults and 63% of children in the U.S. are fearful of needles and this has a direct impact on immunization non-compliance. It is estimated that 7% to 17% of the U.S. population choose to forego vaccinations due to fear of needles. Needle-free jet injectors have been used in the U.S. and other countries to deliver millions of vaccinations.

The PharmaJet Stratis® needle-free injection system received FDA 510(k) clearance in July 2011 for delivery of various medications and vaccines and also achieved CE Marking in 2012 allowing use in the European Economic Area.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rotavirus vaccine in NICUs does not lead to outbreaks, study shows